Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Kerschnitzki
Michael Kerschnitzki
Daiichi Sankyo
Medicine
Atrial fibrillation
Cardiology
Stroke
Internal medicine
3
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose-response model.
2021
European Heart Journal - Cardiovascular Pharmacotherapy
Satyawan B. Jadhav
Ryan L. Crass
Sunny Chapel
Michael Kerschnitzki
William J. Sasiela
Maurice G. Emery
Benny M. Amore
P. Hugh R. Barrett
Gerald F. Watts
Alberico L. Catapano
Show All
Source
Cite
Save
Citations (0)
Efficacy and Safety of Edoxaban Compared to Warfarin According to the Burden of Diseases in Patients with Atrial Fibrillation: Insights from the ENGAGE AF-TIMI 48.
2019
European Heart Journal - Cardiovascular Pharmacotherapy
André M Nicolau
Ramón Corbalán
José C. Nicolau
Christian T. Ruff
Wolfgang Zierhut
Michael Kerschnitzki
Tibor Duris
Steen Juul-Möller
Jüri Voitk
Marco Trevisan
Francesco Nordio
Elliott M. Antman
Robert P. Giugliano
Show All
Source
Cite
Save
Citations (5)
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)
2019
BMC Cardiovascular Disorders
Raffaele De Caterina
Peter J. Kelly
P. Monteiro
Jean-Claude Deharo
Carlo de Asmundis
Esteban López-de-Sá
Thomas Weiss
Johannes Waltenberger
Jan Steffel
Joris R. de Groot
Pierre Lévy
Ameet Bakhai
Wolfgang Zierhut
Petra Laeis
Michael Kerschnitzki
Paul-Egbert Reimitz
Paulus Kirchhof
Show All
Source
Cite
Save
Citations (17)
1